keyword
https://read.qxmd.com/read/38576467/a-case-report-of-recurrent-primary-posterior-mediastinal-perivascular-epithelioid-cell-tumour-compressing-the-right-inferior-pulmonary-vein-atria-and-inferior-vena-cava
#21
Preetham Kumar, Nolan S Maloney, Anees Razzouk, Ramdas G Pai, Padmini Varadarajan
BACKGROUND: Perivascular epithelioid cell tumours (PEComas) are rare soft tissue neoplasms that commonly occur in the uterus, skin, and liver and less commonly in the retroperitoneum, colon, and mediastinum. CASE SUMMARY: A 36-year-old male patient with a history of mediastinal PEComa status post resection, essential hypertension, and atrial fibrillation status post appendage ligation currently not on anticoagulation presented with a 1-week history of fevers, chills, productive cough, chest pain, dyspnoea on exertion, loss of appetite, and general weakness...
April 2024: European Heart Journal. Case Reports
https://read.qxmd.com/read/38576044/long-term-cardiac-effects-of-modern-treatment-for-hodgkin-s-lymphoma
#22
JOURNAL ARTICLE
Anders W Bjerring, Knut Hb Smeland, Thomas Stokke, Kristina H Haugaa, Espen Holte, Assami Rösner, Cecilie E Kiserud, Thor Edvardsen, Sebastian Imre Sarvari
BACKGROUND: Hodgkin's lymphoma (HL) is a hematological malignancy that affects both children and young adults. Traditional treatment is associated with a life-time prevalence of cardiac disease exceeding 50%. In the late 1990s protocols were modified to reduce cancer therapy-related adverse cardiac effects. This study aimed to assess the long-term impact of advances in treatment protocols on the cardiac health of HL survivors (HLS). METHODS: HLS (n = 246) treated between 1997 and 2007 with anthracycline-based chemotherapy in three centers in Norway were included...
April 4, 2024: Cardio-Oncology
https://read.qxmd.com/read/38572905/cardiovascular-screening-of-elderly-athletes
#23
REVIEW
Robert Skalik, Anna Janocha
The permanently growing interest in amateur and professional sports activities among young, middle-aged and elderly athletes raises serious concerns about athletes' health, the safety of physical training, and the sports-related risk of sudden cardiac death and other cardiovascular complications during exercise. In recent years there has been an increasing number of cases of sudden cardiac death during physical effort. At present, life expectancy in the most developed countries grows rapidly and the number of people >65 years dramatically increases...
April 4, 2024: Medycyna Pracy
https://read.qxmd.com/read/38572793/the-paradox-of-platypnoea-orthodeoxia-syndrome
#24
JOURNAL ARTICLE
Benjamin A Leaver, Edward R S Cliff, Michael Jefford, Samuel Fogarty, Dominica Zentner
Platypnoea-orthodeoxia is a rare clinical syndrome characterised by dyspnoea and oxygen desaturation in the upright position which improves when supine. It requires two components: a sufficiently sized anatomical vascular defect (typically intra-cardiac or intra-pulmonary) combined with a functional component that promotes positional right-to-left shunting. We describe the rare occurrence of a patient with platypnoea-orthodeoxia syndrome (POS) because of a paradoxical shunt through a patent foramen ovale caused by a large right atrial line-associated thrombus in a male with metastatic oesophageal cancer undergoing chemotherapy...
April 4, 2024: Internal Medicine Journal
https://read.qxmd.com/read/38570138/mural-infective-endocarditis-with-a-mass-on-the-fossa-ovalis-in-the-right-atrium
#25
Hiroki Harada, Kaito Nakamura, Yuki Koyama, Koki Kikuchi, Hiroyuki Iwano, Mirei Nabuchi-Kawasaki, Yuta Kubono, Megumi Sano, Yoshimoto Serizawa, Hoshi Tetsuya
Infective endocarditis (IE) is a life-threatening disease that affects the endocardial surface of the heart. Although heart valves are commonly involved in IE, in rare cases, vegetation is attached to the cardiac walls without valvular endocardial involvement, which is referred to as mural IE. In this case, a 60-year-old female presented with a seven-day history of fever associated with worsening pain in the right shoulder and left hip. Streptococcus dysgalactiae subsp. Equisimilis was detected in both blood and joint fluid cultures...
April 1, 2024: Journal of Infection and Chemotherapy: Official Journal of the Japan Society of Chemotherapy
https://read.qxmd.com/read/38563855/sex-differences-in-adverse-events-in-medicare-individuals%C3%A2-%C3%A2-%C3%A2-66-years-of-age-post-glioblastoma-treatment
#26
JOURNAL ARTICLE
Mantas Dmukauskas, Gino Cioffi, Kristin A Waite, Andrew E Sloan, Corey Neff, Mackenzie Price, Quinn T Ostrom, Jill S Barnholtz-Sloan
PURPOSE: Glioblastoma (GB) is the most common primary malignant brain tumor with the highest incidence occurring in older adults with a median age at diagnosis of 64 years old. While treatment often improves survival it brings toxicities and adverse events (AE). Here we identify sex differences in treatment patterns and AE in individuals ≥ 66 years at diagnosis with GB. METHODS: Using the SEER-Medicare dataset sex differences in adverse events were assessed using multivariable logistic regression performed to calculate the male/female odds ratio (M/F OR) and 95% confidence intervals [95% CI] of experiencing an AE adjusted for demographic variables and Elixhauser comorbidity score...
April 2, 2024: Journal of Neuro-oncology
https://read.qxmd.com/read/38562897/artificial-intelligence-enhanced-risk-stratification-of-cancer-therapeutics-related-cardiac-dysfunction-using-electrocardiographic-images
#27
Evangelos K Oikonomou, Veer Sangha, Lovedeep S Dhingra, Arya Aminorroaya, Andreas Coppi, Harlan M Krumholz, Lauren A Baldassarre, Rohan Khera
BACKGROUND: Risk stratification strategies for cancer therapeutics-related cardiac dysfunction (CTRCD) rely on serial monitoring by specialized imaging, limiting their scalability. OBJECTIVES: To examine an artificial intelligence (AI)-enhanced electrocardiographic (AI-ECG) surrogate for imaging risk biomarkers, and its association with CTRCD. METHODS: Across a five-hospital U.S.-based health system (2013-2023), we identified patients with breast cancer or non-Hodgkin lymphoma (NHL) who received anthracyclines (AC) and/or trastuzumab (TZM), and a control cohort receiving immune checkpoint inhibitors (ICI)...
March 19, 2024: medRxiv
https://read.qxmd.com/read/38561816/multiple-thrombi-mimicking-metastases-in-the-right-atrium-of-patients-with-non-hodgkin-s-lymphoma-diagnosed-by-multimodal-cardiac-imaging-one-case-report
#28
JOURNAL ARTICLE
Zhiqiang Hu, Shuai Yuan, Yun Mou
BACKGROUND: Right-side heart mass can be found incidentally on routine transthoracic echocardiography (TTE). Accurate diagnosis of cardiac mass often requires more than one imaging method. We present a mid-age woman with non-Hodgkin lymphoma who was found to have multiple right atrial masses mimicking metastases on routine TTE, which were finally diagnosed as thrombi by multimodal cardiac imaging. CASE PRESENTATION: A 52-year-old woman was diagnosed with primary mediastinal diffuse large B cell lymphoma (DLBCL) almost six months prior...
April 1, 2024: Journal of Cardiothoracic Surgery
https://read.qxmd.com/read/38558879/cardiac-morbidity-and-mortality-in-patients-with-sarcoma-a-population-based-study
#29
JOURNAL ARTICLE
Rakan Alanazi, Ahmed Aljizeeri, Ahmed Alsaileek, Azzam Alrashid, Ashwaq Alolayan, Mohammad Alkaiyat, Basel Alenazy, Hussam Shehata, Joud Alqahtani, Husam Ardah, Kanan Alshammari
BACKGROUND: Soft tissue sarcoma (STS) is a rare malignancy that affects soft tissues. It encompasses various subtypes and requires different treatment strategies. Doxorubicin is a commonly used anthracycline in the management of localized and metastatic STS. However, high doses of doxorubicin are associated with cardiotoxicity, which can significantly impact patients' long-term outcomes. This study aimed to evaluate doxorubicin's effect on cardiac function in patients with sarcoma and to correlate the frequency of cardiotoxicity with potential risk factors...
2024: Clinical Medicine Insights. Oncology
https://read.qxmd.com/read/38558679/cardiac-autonomic-and-endothelial-function-in-acute-lymphoblastic-leukaemia-patients-immediately-after-chemotherapy-and-at-the-three-month-follow-up
#30
JOURNAL ARTICLE
Sameer Sameer, Prabhu N, Saranya Kuppusamy, Prashant S Adole, Smita Kayal
INTRODUCTION: Acute lymphoblastic leukemia (ALL) is a malignant uncontrolled overproduction of immature lymphoid cells in blood and bone marrow. The primary treatment of ALL is chemotherapy. Chemotherapy can have myriad systemic side effects, notably cardiovascular derangement. Autonomic derangement occurrence in cancer patients signifies cardiovascular risk in them and is a determinant of cardiovascular morbidity and mortality. Elevated soluble vascular cell adhesion molecule-1 (sVCAM-1) and soluble intercellular adhesion molecule-1 (sICAM-1) levels implicated in the regulation of inflammation indicate endothelial dysfunction...
February 2024: Curēus
https://read.qxmd.com/read/38548357/evaluating-offspring-genomic-and-epigenomic-alterations-after-prenatal-exposure-to-cancer-treatment-in-pregnancy-ge-cip-a-multicentric-observational-study
#31
JOURNAL ARTICLE
Ilana Struys, Carolina Velázquez, Koenraad Devriendt, Lode Godderis, Heidi Segers, Bernard Thienpont, Ruben van Boxtel, Kristel Van Calsteren, Thierry Voet, Vera Wolters, Liesbeth Lenaerts, Frederic Amant
INTRODUCTION: Around 1 in 1000-2000 pregnancies are affected by a cancer diagnosis. Previous studies have shown that chemotherapy during pregnancy has reassuring cognitive and cardiac neonatal outcomes, and hence has been proposed as standard of care. However, although these children perform within normal ranges for their age, subtle differences have been identified. Given that chemotherapeutic compounds can cross the placenta, the possibility that prenatal chemotherapy exposure mutates the offspring's genome and/or epigenome, with potential deleterious effects later in life, urges to be investigated...
March 28, 2024: BMJ Open
https://read.qxmd.com/read/38546223/population-specific-variations-in-kcnh2-predispose-patients-to-delayed-ventricular-repolarization-upon-dihydroartemisinin-piperaquine-therapy
#32
JOURNAL ARTICLE
Mahamadou D Camara, Yitian Zhou, Antoine Dara, Mamadou M Tékété, Taís Nóbrega de Sousa, Sékou Sissoko, Laurent Dembélé, Nouhoun Ouologuem, Amadou Hamidou Togo, Mohamed L Alhousseini, Bakary Fofana, Issaka Sagara, Abdoulaye A Djimde, Pedro J Gil, Volker M Lauschke
Dihydroartemisinin-piperaquine is efficacious for the treatment of uncomplicated malaria and its use is increasing globally. Despite the positive results in fighting malaria, inhibition of the Kv11.1 channel (hERG; encoded by the KCNH2 gene) by piperaquine has raised concerns about cardiac safety. Whether genetic factors could modulate the risk of piperaquine-mediated QT prolongations remained unclear. Here, we first profiled the genetic landscape of KCNH2 variability using data from 141,614 individuals. Overall, we found 1,007 exonic variants distributed over the entire gene body, 555 of which were missense...
March 28, 2024: Antimicrobial Agents and Chemotherapy
https://read.qxmd.com/read/38544901/structure-activity-relationship-of-anticancer-drug-candidate-quinones
#33
JOURNAL ARTICLE
Nadire Özenver, Neslihan Sönmez, Merve Yüzbaşioğlu Baran, Merve Yüzbaşioğlu Baran, Ayşe Uz, Lütfiye Ömür Demirezer
Breast cancer is one of the most prevalent cancer types worldwide. Chemotherapy is a substantial approach in the management of breast cancer despite the occurrence of chemotherapy-associated side effects and the development of multidrug resistance in cancer cells. At this point, a variety of quinone derivatives may represent potential as possible anticancer drug candidates due to possessing structural similarity towards clinically used anticancer drugs like doxorubicin. Therefore, we investigated the cytotoxic effects of various quinone derivatives with structural diversity towards a variety of breast cancer cells...
2024: Turkish Journal of Chemistry
https://read.qxmd.com/read/38541800/cardiovascular-toxicity-of-antineoplastic-treatments-in-hematological-diseases-focus-on-molecular-mechanisms-to-improve-therapeutic-management
#34
REVIEW
Serena Barachini, Gabriele Buda, Iacopo Petrini
In recent years, advancements in the treatment of hematologic neoplasms have led to more effective and less toxic therapeutic schemes, resulting in prolonged patient life expectancy. However, the success of these treatments has also brought about an increased prevalence of cardiovascular adverse events, becoming a significant concern for the growing population of cancer survivors. Antineoplastic therapies, targeting both tumor and organ vessels, contribute to vascular toxicity, influenced by genetic factors and pre-existing vascular diseases...
March 9, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38541221/disseminated-enterovirus-infection-in-a-patient-affected-by-follicular-lymphoma-treated-with-obinutuzumab-a-case-report-and-a-narrative-review-of-the-literature
#35
REVIEW
Tommaso Lupia, Silvia Corcione, Elena Staffilano, Roberta Bosio, Antonio Curtoni, Alessandro Busca, Francesco Giuseppe De Rosa
Background and Objectives : the principal purpose of this literature review is to cluster adults with hematological malignancies after treatment or on maintenance with obinutuzumab who experienced disseminated EV infection to understand clinical characteristics and outcome of this rare condition in these patients. We report the first clinical case of a male affected by follicular lymphoma treated with immune-chemotherapy including obinutuzumab who was affected by disseminated EV infection with cardiovascular involvement...
March 18, 2024: Medicina
https://read.qxmd.com/read/38539042/neoadjuvant-chemoimmunotherapy-confers-survival-advantage-for-patients-undergoing-sleeve-lobectomy
#36
JOURNAL ARTICLE
Tao Chen, Jialiang Wen, Yiming He, Yifan Zhong, Jiajun Deng, Qiankun Chen, Yunlang She, Lei Jiang, Dong Xie, Deping Zhao, Chang Chen
OBJECTIVES: It has been demonstrated that neoadjuvant immune checkpoint inhibitor (ICI) plus chemotherapy was safe and feasible referred to neoadjuvant chemotherapy for patients with non-small cell lung cancer (NSCLC) undergoing sleeve lobectomy. Nevertheless, no survival data were reported in the previous researches. Therefore, we conducted this study to compare neoadjuvant ICI plus chemotherapy versus neoadjuvant chemotherapy followed by sleeve lobectomy for long-term survival outcomes...
March 27, 2024: European Journal of Cardio-thoracic Surgery
https://read.qxmd.com/read/38535135/comparison-of-echocardiography-and-myocardial-scintigraphy-to-detect-cancer-therapy-related-cardiovascular-toxicity-in-breast-cancer-patients
#37
JOURNAL ARTICLE
Yuko Harada, Kyosuke Shimada, Satoshi John Harada, Tomomi Sato, Yukino Kubota, Miyoko Yamashita
The mortality rate of cancer patients has been decreasing; however, patients often suffer from cardiac disorders due to chemotherapy or other cancer therapies (e.g., cancer-therapy-related cardiovascular toxicity (CVR-CVT)). Therefore, the field of cardio-oncology has drawn more attention in recent years. The first European Society of Cardiology (ESC) guidelines on cardio-oncology was established last year. Echocardiography is the gold standard for the diagnosis of CVR-CVT, but many breast cancer patients are unable to undergo echocardiography due to their surgery wounds or anatomical reasons...
February 21, 2024: Journal of Imaging
https://read.qxmd.com/read/38531031/heart-failure-related-to-contemporary-breast-cancer-treatment
#38
JOURNAL ARTICLE
Megan Durkin, Neisha DeJesus
This article addresses cardiotoxicity in patients with breast cancer who are treated with anthracyclines and/or anti-human epidermal growth factor 2 (HER2) therapy, namely doxorubicin and trastuzumab. Development of concise clinical guidelines for chemotherapy-induced heart failure is ongoing. Through identification of specific risk factors and clinical predictors of cardiotoxicity, clinicians are able to better understand and define effective monitoring strategies and optimize patient care. Close cardiac monitoring is recommended for patients throughout treatment with anthracyclines and anti-HER2 therapy...
April 1, 2024: JAAPA: Official Journal of the American Academy of Physician Assistants
https://read.qxmd.com/read/38530978/perioperative-immune-checkpoint-blockades-improve-prognosis-of-resectable-non-small-cell-lung-cancer
#39
JOURNAL ARTICLE
Yu Tian, Zhichao Liu, Hanbo Pan, Hongda Zhu, Ningyuan Zou, Long Jiang, Ziming Li, Jia Huang, Yingjie Hu, Qingquan Luo
OBJECTIVES: Immune checkpoint blockades (ICB) have been proven to improve prognosis of non-small cell lung (NSCLC) in the neoadjuvant setting, while whether its perioperative use could bring extra benefit remained unidentified. We aimed to demonstrate the prognostic benefit of perioperative ICB over preoperative-only use and investigate who could benefit from this "sandwich ICB therapy". METHODS: Patients undergoing neoadjuvant therapy followed by surgery from 2018 to 2022 was retrospectively reviewed, and were divided into four groups based on the perioperative regimens: pre-ICB + post-CT, pre-ICB-only, pre-CT + post-ICB, and pre-CT-only...
March 26, 2024: European Journal of Cardio-thoracic Surgery
https://read.qxmd.com/read/38522599/risk-of-clinically-significant-cardiovascular-disease-associated-with-postoperative-radiotherapy-in-non-small-cell-lung-cancer-patients-receiving-surgical-resection-followed-by-adjuvant-chemotherapy-a-korean-nationwide-cohort-study
#40
JOURNAL ARTICLE
Jeanny Kwon, Byoung Hyuck Kim
BACKGROUND: There are no large-scale datasets that analyze the relationship between postoperative radiotherapy (PORT) and various cardiovascular diseases (CVDs) in patients with locally advanced non-small cell lung cancer (NSCLC). Therefore, we aimed to investigate the incidences of CVDs with PORT using a national population-based database. METHODS: Patients diagnosed with NSCLC who underwent curative surgery followed by adjuvant chemotherapy were included from 2007 to 2017...
March 22, 2024: Radiotherapy and Oncology
keyword
keyword
106610
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.